Royal Philips has announced the launch of its next generation image-guided therapy platform, deemed Azurion.
Philips designed the platform to allow clinicians to easily perform a variety of routine and complex procedures. Meant for use in interventional labs, Azurion is but another example of medical device products with a strong value-based sales pitch around controlling costs and improving care standards.
“For over 30 years, we’ve pioneered minimally invasive treatments that help our patients get back to their daily lives,” said Dr. Barry T. Katzen, founder and chief medical executive of the Miami Cardiac and Vascular Institute, Baptist Health South Florida.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Philips has a value argument for new image guided therapy platform appeared first on MassDevice.
from MassDevice http://ift.tt/2lwcBvb
Cap comentari:
Publica un comentari a l'entrada